Longduoduo Company Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LDDD research report →
Companywww.longduoduo.net
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy.
- CEO
- Hongxiao Zhou
- IPO
- 2023
- Employees
- 52
- HQ
- Hohhot, CN
Price Chart
Valuation
- Market Cap
- $15.31M
- P/E
- -43.42
- P/S
- 7.18
- P/B
- 20.77
- EV/EBITDA
- -50.52
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 98.83%
- Op Margin
- -20.17%
- Net Margin
- -16.54%
- ROE
- -36.07%
- ROIC
- -50.05%
Growth & Income
- Revenue
- $4.26M · -42.32%
- Net Income
- $460.44K · -63.33%
- EPS
- $0.02 · -63.57%
- Op Income
- $552.68K
- FCF YoY
- -21.24%
Performance & Tape
- 52W High
- $4.99
- 52W Low
- $0.51
- 50D MA
- $0.51
- 200D MA
- $1.15
- Beta
- 0.36
- Avg Volume
- 197.832
Get TickerSpark's AI analysis on LDDD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 25, 24 | Ma Jiayang | other | 0 |
| Nov 27, 23 | Shan Bo | other | 0 |
| Nov 27, 23 | Xu Huibo | other | 0 |
| Nov 27, 23 | Wu Binbin | other | 0 |
| Nov 27, 23 | Li Zhijie | other | 0 |
| Nov 27, 23 | Zhang Liang | other | 0 |
| Nov 27, 23 | Hongxiao Zhou | other | 0 |
| Nov 27, 23 | Liping Kang | other | 0 |
Our LDDD Coverage
We haven't published any research on LDDD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LDDD Report →